|
ZSCAN12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.50679996152792E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.72929465086713E-11 |
| Normal-vs-Stage2 |
3.78109999998877E-06 |
| Normal-vs-Stage3 |
2.25459984015686E-10 |
| Normal-vs-Stage4 |
1.02070019103451E-10 |
| Stage1-vs-Stage2 |
8.623400E-01 |
| Stage1-vs-Stage3 |
1.920150E-02 |
| Stage1-vs-Stage4 |
9.944300E-03 |
| Stage2-vs-Stage3 |
7.120300E-02 |
| Stage2-vs-Stage4 |
2.280300E-02 |
| Stage3-vs-Stage4 |
4.316400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.57820001511766E-09 |
| Normal-vs-AfricanAmerican |
2.900200E-03 |
| Normal-vs-Asian |
5.34410000030405E-07 |
| Caucasian-vs-AfricanAmerican |
1.626360E-01 |
| Caucasian-vs-Asian |
4.895600E-01 |
| AfricanAmerican-vs-Asian |
5.069800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.50129994494586E-09 |
| Normal-vs-Female |
2.17770002031159E-09 |
| Male-vs-Female |
3.453600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.56260021483479E-10 |
| Normal-vs-Age(41-60Yrs) |
5.43750000581156E-09 |
| Normal-vs-Age(61-80Yrs) |
2.50160003822941E-10 |
| Normal-vs-Age(81-100Yrs) |
7.376300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.617600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.040000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.068400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.596000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.822600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.773600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.75825999999546E-05 |
| Classical-VS-Follicular |
8.521400E-01 |
| Classical-VS-Other |
7.341800E-01 |
| Classical-VS-Normal |
4.81330000301483E-08 |
| Tall-VS-Follicular |
1.786290E-04 |
| Tall-VS-Other |
1.111810E-01 |
| Tall-VS-Normal |
2.73914224635519E-12 |
| Follicular-VS-Other |
8.138000E-01 |
| Follicular-VS-Normal |
1.87960000008758E-07 |
| Other-VS-Normal |
4.442000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.96510030470165E-10 |
| Normal-vs-N1 |
3.07269987231962E-10 |
| N0-vs-N1 |
4.460100E-02 |
|
|
